Tech industry executives, employees and investors who do not have diabetes take the drug to combat effects of aging, such as reduced cancer risk, according to the report. Additionally, metformin is a low-risk drug, with side effects of prolonged use being diarrhea, slow blood sugar and abdominal pain, CNBC reports.
“Theoretically someone can take it without diabetes, as there are some known side effects but they’re usually tolerated if the patient gradually increases dosage over time,” said Greg Burrell, MD, a practicing physician and the co-founder of Carbon Health, a mobile-based connected healthcare network in San Francisco, told CNBC.
Medical experts told CNBC because there is a lack of research on metformin’s effect on people without diabetes, they are conflicted on its use among those individuals.
More articles on health IT:
5 states with most, fewest technology companies
Facebook employees had access to 600M user passwords
FDA issues safety alert for Medtronic defibrillators due to cybersecurity vulnerabilities
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
